Your session is about to expire
← Back to Search
Exercise Treatment Group for Exercise (SCA Trial)
N/A
Waitlist Available
Led By Foluso J Ogunsile, MD
Research Sponsored by Memorial Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
SCA Trial Summary
This trial will test if exercise can improve the quality of life for adults with sickle cell anemia who also have cardiopulmonary disease.
Eligible Conditions
- Exercise
- Sickle Cell Disease
- Cardiovascular Disease
SCA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Specific exercise regimen for those living with sickle cell disease
SCA Trial Design
1Treatment groups
Experimental Treatment
Group I: Exercise Treatment GroupExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Memorial Healthcare SystemLead Sponsor
8 Previous Clinical Trials
1,170 Total Patients Enrolled
1 Trials studying Exercise
10 Patients Enrolled for Exercise
University of Alabama at BirminghamLead Sponsor
1,581 Previous Clinical Trials
2,277,914 Total Patients Enrolled
9 Trials studying Exercise
586 Patients Enrolled for Exercise
Foluso J Ogunsile, MDPrincipal InvestigatorMemorial Healthcare System
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger